These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 813410)

  • 21. [Haemolytic disease of the new-born by blood-factor incompatibility other than Rh(d) and ABO (author's transl)].
    Schellong G; Sandmann G; Fischer K; Poschmann A
    Dtsch Med Wochenschr; 1976 Oct; 101(44):1591-7. PubMed ID: 824115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation between bilirubin- and protein-concentration in amniotic fluid in Rh incompatibility (author's transl)].
    Markus P; Kopecky P
    Z Geburtshilfe Perinatol; 1973 Dec; 177(6):411-22. PubMed ID: 4788130
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prenatal diagnosis of hemolytic disease of the fetus according to the data of study of the amniotic fluid].
    Savel'eva GM; Tabolin VA; Volodin NN; Efimov MS; Levantovskaia IN
    Vopr Okhr Materin Det; 1975 Aug; 20(8):10-5. PubMed ID: 809927
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prenatal determination of the fetal blood group].
    Meroni P; Della Torre L
    Ann Ostet Ginecol Med Perinat; 1969 Jul; 91(7):497-507. PubMed ID: 4997558
    [No Abstract]   [Full Text] [Related]  

  • 25. Intrauterine intravascular transfusion for severe erythroblastosis fetalis: how much to transfuse?
    Plecas DV; Chitkara U; Berkowitz GS; Lapinski RH; Alvarez M; Berkowitz RL
    Obstet Gynecol; 1990 Jun; 75(6):965-9. PubMed ID: 2342745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Report of experiences in 20 years use of intrauterine fetal transfusion in severe Rh-induced hemolytic disease of newborn].
    Schwarzlos G; Stark KH; During R; Hille M; Müller S; Plesse R; Scheunemann P; Wilken H
    Zentralbl Gynakol; 1988; 110(1):18-24. PubMed ID: 3354274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the prenatal diagnosis of morbus haemolyticus neonatorum through amniotic fluid analysis].
    Seidenschnur G; Neumayer E; Stark KH; Eggers H; Wulf E
    Zentralbl Gynakol; 1967 Sep; 89(39):1412-20. PubMed ID: 4969825
    [No Abstract]   [Full Text] [Related]  

  • 28. [Supervision of pregnant women isoimmunized with the rhesus factor. Significance and interpretation of the position of optic indices on the Liley diagram (425 cases)].
    Blanchard A; Merger R
    J Gynecol Obstet Biol Reprod (Paris); 1972 Mar; 1(2):107-31. PubMed ID: 4626034
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intrauterine exchange transfusion in Rh immunization].
    Bollmann R; Schilling H; Ihle W; Möckel A; Zienert A
    Zentralbl Gynakol; 1988; 110(1):54-9. PubMed ID: 3281398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The development of children following intra-uterine transfusions in severe Rh-erythroblastosis (author's transl)].
    Schellong G; Palm D; Maier-Becker EM; Quakernack K
    Z Geburtshilfe Perinatol; 1977 Feb; 181(1):36-45. PubMed ID: 848077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of pregnancy complicated by Rh-immunization. Review with respect to own investigations and results.
    Bartsch FK
    Pathologica; 1972; 64(929):139-48. PubMed ID: 4210413
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of severe Rhesus erythroblastosis].
    Bichler A; Frisch H
    Padiatr Padol; 1977; 12(4):339-48. PubMed ID: 409979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Severe fetal hemolytic disease. Evaluation and successful treatment by means of cordocentesis].
    Schnapp C; Alcalde JL; de la Jara C; Guiloff E
    Rev Chil Obstet Ginecol; 1989; 54(5):281-6; discussion 286-7. PubMed ID: 2490416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Feto-maternal incompatibility in the Rh system. Hemolytic disease of the fetus].
    Merger R
    J Gynecol Obstet Biol Reprod (Paris); 1972 Mar; 1(2):105-6. PubMed ID: 4626033
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current management during pregnancy of a woman immunized against the Rhesus factor].
    Boreau T
    Gynecol Obstet (Paris); 1969; 68(5):445-52. PubMed ID: 4983458
    [No Abstract]   [Full Text] [Related]  

  • 36. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of severe rhesus isoimmunization by repeated transfusions in utero].
    Lemaire B; Michaud P; Tescher M
    Rev Fr Gynecol Obstet; 1992 Dec; 87(12):587-90. PubMed ID: 1485075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of the Rh-negative mother.
    Beck RP
    Can Med Assoc J; 1973 Nov; 109(9):903-4. PubMed ID: 4127213
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnosis and therapy in fetuses at risk in Rh isoimmunization].
    Calda P; Zizka Z; Rezábek K; Masata J; Bendl J
    Cesk Gynekol; 1993 Dec; 58(6):278-82. PubMed ID: 8293503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemical determination of bilirubin in the amniotic fluid in rhesus-induced morbus hemolyticus].
    Halle E; Tsamaloukas I; Halle H
    Zentralbl Gynakol; 1973 Sep; 95(38):1349-52. PubMed ID: 4203839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.